Menu
GeneBe

1-158678434-A-G

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_StrongPP5_Very_Strong

The NM_003126.4(SPTA1):​c.779T>C​(p.Leu260Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,613,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000068 ( 0 hom. )

Consequence

SPTA1
NM_003126.4 missense

Scores

8
9
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 8.48
Variant links:
Genes affected
SPTA1 (HGNC:11272): (spectrin alpha, erythrocytic 1) This gene encodes a member of a family of molecular scaffold proteins that link the plasma membrane to the actin cytoskeleton and functions in the determination of cell shape, arrangement of transmembrane proteins, and organization of organelles. The encoded protein is primarily composed of 22 spectrin repeats which are involved in dimer formation. It forms a component of the erythrocyte plasma membrane. Mutations in this gene result in a variety of hereditary red blood cell disorders, including elliptocytosis-2, pyropoikilocytosis, and spherocytosis, type 3. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 12 ACMG points.

PP3
MetaRNN computational evidence supports a deleterious effect, 0.991
PP5
Variant 1-158678434-A-G is Pathogenic according to our data. Variant chr1-158678434-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 12844.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr1-158678434-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SPTA1NM_003126.4 linkuse as main transcriptc.779T>C p.Leu260Pro missense_variant 6/52 ENST00000643759.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SPTA1ENST00000643759.2 linkuse as main transcriptc.779T>C p.Leu260Pro missense_variant 6/52 NM_003126.4 P1P02549-1

Frequencies

GnomAD3 genomes
AF:
0.0000526
AC:
8
AN:
152204
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000193
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000120
AC:
3
AN:
249130
Hom.:
0
AF XY:
0.0000148
AC XY:
2
AN XY:
135138
show subpopulations
Gnomad AFR exome
AF:
0.000194
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000684
AC:
10
AN:
1461496
Hom.:
0
Cov.:
31
AF XY:
0.00000825
AC XY:
6
AN XY:
727058
show subpopulations
Gnomad4 AFR exome
AF:
0.000239
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000331
GnomAD4 genome
AF:
0.0000526
AC:
8
AN:
152204
Hom.:
0
Cov.:
32
AF XY:
0.0000672
AC XY:
5
AN XY:
74350
show subpopulations
Gnomad4 AFR
AF:
0.000193
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Bravo
AF:
0.0000453
ExAC
AF:
0.0000248
AC:
3

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:4
Likely pathogenic, criteria provided, single submitterclinical testingGeneDxSep 30, 2022Observed in individuals with hereditary elliptocytosis, however these individuals were not screened for variants in other genes associated with hereditary elliptocytosis (Glele-Kakai et al., 1996); Published functional studies demonstrate that L260P increased the stability of the closed dimer state, reduced tetramer assembly, and resulted in membrane destabilization (Randles et al., 2013; Harper et al., 2013); In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 3597773, 23974198, 2794061, 8857939, 31130284, 23241237, 32641076) -
Likely pathogenic, criteria provided, single submitterclinical testingInvitaeNov 08, 2022Experimental studies have shown that this missense change affects SPTA1 function (PMID: 23974198). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SPTA1 protein function. ClinVar contains an entry for this variant (Variation ID: 12844). This missense change has been observed in individual(s) with autosomal dominant hereditary elliptocytosis and autosomal recessive hereditary pyropoikilocytosis (PMID: 2794061, 8857939, 18815189, 31130284, 32641076). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs121918634, gnomAD 0.02%). This sequence change replaces leucine, which is neutral and non-polar, with proline, which is neutral and non-polar, at codon 260 of the SPTA1 protein (p.Leu260Pro). -
Pathogenic, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJun 08, 2023- -
Pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvityOct 24, 2023- -
Elliptocytosis 2 Pathogenic:3
Pathogenic, no assertion criteria providedliterature onlyOMIMOct 01, 1989- -
Pathogenic, criteria provided, single submitterclinical testingAl Jalila Children’s Genomics Center, Al Jalila Childrens Speciality HospitalMar 29, 2021- -
Likely pathogenic, criteria provided, single submitterresearchCenter for Genomic Medicine, King Faisal Specialist Hospital and Research CenterMar 25, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.93
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Pathogenic
0.37
CADD
Benign
23
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.72
D;D
Eigen
Uncertain
0.63
Eigen_PC
Uncertain
0.44
FATHMM_MKL
Uncertain
0.95
D
M_CAP
Uncertain
0.24
D
MetaRNN
Pathogenic
0.99
D;D
MetaSVM
Uncertain
0.64
D
MutationAssessor
Pathogenic
3.6
H;H
MutationTaster
Benign
1.0
A;A
PrimateAI
Uncertain
0.53
T
PROVEAN
Pathogenic
-6.3
D;.
REVEL
Pathogenic
0.84
Sift
Pathogenic
0.0
D;.
Sift4G
Uncertain
0.013
D;.
Polyphen
1.0
D;D
Vest4
0.93
MutPred
0.91
Loss of stability (P = 0.024);Loss of stability (P = 0.024);
MVP
0.96
MPC
0.26
ClinPred
0.98
D
GERP RS
4.7
Varity_R
0.97
gMVP
0.91

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs121918634; hg19: chr1-158648224; COSMIC: COSV100934803; API